Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent L-lysine-containing domains
Artículo
Open/ Download
Publication date
2017Metadata
Show full item record
Cómo citar
Gonzàlez Gronow, Mario
Cómo citar
Myelin basic protein stimulates plasminogen activation via tissue plasminogen activator following binding to independent L-lysine-containing domains
Author
Abstract
Myelin basic protein (MBP) is a key component of myelin, the specialized lipid membrane that encases
the axons of all neurons. Both plasminogen (Pg) and tissue-type plasminogen activator (t-PA) bind to
MBP with high affinity. We investigated the kinetics and mechanisms involved in this process using
immobilized MBP and found that Pg activation by t-PA is significantly stimulated by MBP. This mechanism
involves the binding of t-PA via a lysine-dependent mechanism to the Lys91 residue of the MBP
NH2-terminal region Asp82 -Pro99, and the binding of Pg via a lysine-dependent mechanism to the Lys122
residue of the MBP COOH-terminal region Leu109-Gly126. In this context, MBP mimics fibrin and because
MBP is a plasmin substrate, our results suggest direct participation of the Pg activation system on MBP
physiology.
Patrocinador
Fondo Nacional de
Desarrollo Cientίfico y Tecnolόgico de Chile, FONDECYT No 1130451
Indexation
Artículo de publicación ISI
Identifier
URI: https://repositorio.uchile.cl/handle/2250/149113
DOI: http://dx.doi.org/10.1016/j.bbrc.2017.06.131
Quote Item
Biochemical and Biophysical Research Communications 490 (2017) 855-860
Collections
The following license files are associated with this item:
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile
Related items
Showing items related by title, author, creator and subject.
-
Smith, P. C.; Martínez, J. (INT AMER ASSOC DENTAL RESEARCHI A D R/A A D R, 2006-02)Transforming Growth Factor-beta 1 (TGF-beta 1) plays a key role in connective tissue remodeling and inflammation. Under pathological conditions, like periodontal disease, fibroblasts may display an altered response to this ...
-
Experiencia de trombolisis sistematizada en infarto cerebral agudo en un hospital público de Chile Figueroa Reyes, Tatiana; Sáez Méndez, David; Mansilla, Eloy; Sánchez V., Rodrigo; Nogales Gaete, Jorge; Delgado B., Iris (2011)Background: The only accepted treatment for acute ischemic stroke is thrombolysis with recombinant tissue plasminogen activator (t-PA). It was implemented in Chile in 1996, although its use was mainly restricted in Chile ...
-
Robinson, Thompson G.; Wang, Xia; Arima, Hisatomi; Bath, Philip M.; Billot, Laurent; Broderick, Joseph P.; Demchuk, Andrew M.; Donnan, Geoffery A.; Kim, Jong S.; Lavados Germain, Pablo Manuel; Lee, Tsong Hai; Lindley, Richard I.; Martins, Sheila C. O.; Olavarria, Veronica V.; Pandian, Jeyaraj D.; Parsons, Mark W.; Pontes Neto, Octavio M.; Ricci, Stefano; Sato, Shoichiro; Sharma, Vijay K.; Nguyen, Thang H.; Wang, Ji Guang; Woodward, Mark; Chalmers, John; Anderson, Craig S. (Lippincott Williams & Wilkins, 2017)Background and Purpose-Many patients receiving thrombolysis for acute ischemic stroke are on prior antiplatelet therapy (APT), which may increase symptomatic intracerebral hemorrhage risk. In a prespecified subgroup analysis, ...